WILLIAM M. CONLEY, District Judge.
In this patent lawsuit, plaintiff Wisconsin Alumni Research Foundation ("WARF") alleges that defendant Apple Inc. infringes U.S. Patent No. 5,781,752 ("the `752 patent"), titled "Table Based Data Speculation Circuit for Parallel Processing Computer." Currently pending before the court is WARF's motion to dismiss Apple's affirmative defense and counterclaim for inequitable conduct. (Dkt. #44.) Having reviewed the briefs and the relevant case law, the court will grant WARF's motion. Because WARF has not shown that amendment would be futile, however, the court will dismiss the counterclaim without prejudice.
On January 31, 2014, WARF filed its complaint alleging infringement of the `752 patent. That patent discloses a "predictor circuit [that] permits advanced execution of instructions depending for their data on previous instructions by predicting such dependencies based on previous mis-speculations detected at the final stages of processing." (`752 patent (dkt. #1-1) Abstract.) By way of illustration, Claim 1 provides:
(`752 patent, at 14:36-53 (emphasis added).)
WARF alleges that a certain number of Apple's processors (including but not limited to the A7 processor) and products that include such processors (e.g., the iPhone 5S, iPad Air, and iPad Mini with Retina Display) infringe the '752 patent. (See Compl. (dkt. #1) ¶¶ 4-5, 21.) In its Amended Answer, Apple disputes infringement and affirmatively alleges that the '752 patent is unenforceable due to inequitable conduct. (1st Am. Answer & Counterclaims (dkt. #40) ¶¶ 21-54 [hereinafter "Counterclaims"].)
A motion to dismiss does not test the merits of a pleading, but rather the sufficiency of its allegations as pled. Gibson v. City of Chicago, 910 F.2d 1510, 1520 (7th Cir. 1990). Dismissal of a claim under Federal Rule of Civil Procedure 12(b)(6) is warranted when the pleading "fails to allege enough facts to raise a reasonable expectation that discovery will reveal evidence supporting [those] allegations." Semiconductor Energy Lab. Co. v. Samsung Elecs. Co., 749 F.Supp.2d 892, 901 (W.D. Wis. 2010). Where, as here, a party makes an allegation of fraud on the PTO, Rule 9(b) of the Federal Rules of Civil Procedure also requires dismissal if the claim is not pled with sufficient factual particularity. Id.; see also Exergen Corp. v. Wal-Mart Stores, Inc., 575 F.3d 1312, 1318 (Fed. Cir. 2009) (addressing inequitable conduct in the Rule 12(b)(6) context).
To establish that a patent is unenforceable because of inequitable conduct, the challenger must prove "by clear and convincing evidence" that an individual associated with the filing and prosecution of the application: (1) made an affirmative representation of material fact, failed to disclose material information or submitted false material information; and (2) intended to deceive the Patent and Trademark Office. Star Scientific, Inc. v. R.J. Reynolds Tobacco Co., 537 F.3d 1357, 1365 (Fed. Cir. 2008). Thus, to state a claim for inequitable conduct, a pleading must contain "sufficient allegations of underlying facts from which a court may reasonably infer that an individual (1) knew of the withheld material information or the falsity of the information, and (2) withheld or misrepresented this information with a specific intent to deceive the PTO." Exergen, 575 F.3d at 1328-29; see also Semiconductor Energy, 749 F. Supp. 2d at 902. To plead these underlying facts with sufficient particularity, a party must identify "the specific who, what, when, where, and how of the material misrepresentation or omission." Exergen, 575 F.3d at 1327 (citing DiLeo v. Ernst & Young, 901 F.2d 624, 627 (7th Cir. 1990)).
Apple's pleading of materiality falls short both generally and with respect to the specific prior art references.
To begin, a party alleging inequitable conduct must first identify specific facts from which the court could infer that at least one claim of the patent would not have issued if the Examiner had been aware of the references allegedly withheld. See Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276, 1291 (Fed. Cir. 2011) ("[T]he materiality required to establish inequitable conduct is but-for materiality . . . . [P]rior art is but-for material if the PTO would not have allowed a claim had it been aware of the undisclosed prior art."). More specifically, the Federal Circuit has held that in pleading inequitable conduct, a party must "identify the particular claim limitations, or combination of claim limitations, that are supposedly absent from the information of record" in sufficient detail to "explain both `why' the withheld information is material and not cumulative, and `how' an examiner would have used this information in assessing the patentability of the claims." Exergen, 575 F.3d at 1329-30 (citing Larson Mfg. Co. v. Aluminart Prods. Ltd., 559 F.3d 1317, 1333 (Fed. Cir. 2009)).
From the outset, there are problems with Apple's allegations of materiality. As WARF points out, Apple merely alleges that the Examiner would "likely" not have allowed the claims to issue had Drs. Sohi and Moshovos disclosed the two references. (Counterclaims (dkt. #40) ¶¶ 28, 39, 50.)
Perhaps this is all Apple's counsel could allege in good faith at the outset of the suit, but the choice of the word "likely" is not entirely in line with the but-for materiality that a claim of inequitable conduct requires. Either the PTO would have disallowed the claim upon disclosure of the prior art references or it would not. Anything in between, as inferred from Apple's use of the word "likely," fails to meet the threshold required by Rule 9(b).
Apple's inequitable conduct defense is primarily founded on the Steely Patent. With respect to that reference, the counterclaim alleges the following:
(Counterclaims (dkt. #40) ¶¶ 29-30 (emphasis added).)
As previously noted, the Federal Circuit explicitly addressed the pleading standards applicable to a claim of inequitable conduct in Exergen. To satisfy the heightened pleading requirements of Rule 9(b), "the pleading must identify which claims, and which limitations in those claims, the withheld references are relevant to, and where in those references the material information is found." Exergen, 575 F.3d at 1329; see also, e.g., Milwaukee Elec. Tool Corp. v. Hitachi Koki Co., 2012 WL 1952977, at *7 (E.D. Wis. May 29, 2012) (emphasis added) (dismissing inequitable conduct allegations where the "Invalidity Contentions" for the patents-in-suit did "not sufficiently explain where in each item of prior art the elements of the claims . . . are found") (quoting Exergen). Furthermore, the pleading must go beyond stating generally that withheld references are material and not cumulative; it must "identify the particular claim limitations, or combination of claim limitations, that are supposedly absent from the information of record" in order to "explain both `why' the withheld information is material and not cumulative, and `how' an examiner would have used this information in assessing the patentability of the claims." 575 F.3d at 1329-30 (citing Larson, 559 F.3d at 1333).
Apple's current allegations entirely fail to meet this standard for at least two reasons. First, merely alleging that the Steely reference discloses the same "subject matter" as the `752 patent falls woefully short of the correct level of particularity to plead inequitable conduct premised on anticipation, since Apple makes no attempt to identify (1) the particular claim limitations, or combination of limitations, that are supposedly absent from the record before the Examiner, and (2) the specific material, noncumulative disclosures in the Steely Patent.
Second, Apple alleges, without further detail, that the Steely Patent "in combination with other prior art . . . invalidates claims of the '752 patent." (Counterclaims (dkt. #40) ¶ 30.) This verbiage is similarly insufficient. If the basis for Apple's inequitable conduct claim is that the `752 patent would have been deemed obvious had the Examiner considered the Steely Patent, then Apple must plead as much with specificity in an amended counterclaim. Stating simply that Steely Patent in "combination with other prior art" leaves critical questions unanswered. What is the other prior art of which Apple speaks? And why would the skilled addressee be motivated to combine in the first place? Nothing in the current counterclaim seeks to supply these missing factual allegations.
Even if Apple intends to rely on a theory that the Steely Patent can be combined with common general knowledge of the person skilled in the art, then it must make some effort to identify that knowledge. While a high standard, this is precisely what Rule 9(b) and Federal Circuit case law require given the seriousness of an inequitable conduct claim. See Therasense, 649 F.3d at 1289-90 (discussing inequitable conduct doctrine as "a doctrine that has been overused to the detriment of the public"). Without demanding specificity, not only is the rule's purpose violated, but the good names of inventors will continue to be dragged through the mud of spurious claims.
This is not to say that there are not facts that can be pled to support Apple's inequitable conduct defense with specificity. On the contrary, Apple has filed a Petition with the Patent Office for Inter Partes Review ("IPR"). Given the specificity and detail alleged in its IPR Petition, Apple should not find the process of identifying combinations in this litigation unduly burdensome. (See dkt #52-1.)
Instead, what the court is pointing out is that Apple has yet to plead those facts in this case, leaving this court to speculate. As such, the failure to identify any specific prior art reference or common general knowledge that in combination with the Steely Patent makes the `752 patent obvious renders Apple's counterclaim wholly deficient.
Apple's inequitable conduct defense also relies on the Smith Article. With respect to that reference, it alleges the following:
(Counterclaims (dkt. #40) ¶¶ 43-44 (emphasis added).)
As set forth above, Apple does not allege that the Smith Article is novelty-defeating by itself. Instead, Apple alleges that the reference is merely "analogous"
Apple also fails to plead the required element of deceptive intent for each of its inequitable conduct claims. Under Exergen, to plead scienter adequately, a party must allege sufficient facts to infer actual knowledge of
Under this standard, deficiencies with the intent prong exist with regard to both the Steely Patent and the Smith Article. First, the same deficiencies with respect to materiality undermine Apple's attempt to plead scienter: Apple does not identify the specific information alleged to be material to the `752 patent. With respect to the Steely Patent, Apple alleges only that Drs. Moshovos and Sohi were aware of the Steely Patent generally (Counterclaims (dkt. #40) ¶ 24), and that Moshovos recognized that the Steely Patent "identified the same problem as the `752 patent earlier than did he and his coinventors." (Id. at ¶ 25.) With respect to the Smith Article, Apple similarly alleges only that Drs. Moshovos and Sohi were aware of the Smith Article generally and that they were aware of "the materiality of the Smith Article's discussion of `branch prediction' to the subject matter of the `752 patent." (Id. at ¶ 26.)
These threadbare allegations do not make plausible Apple's theory that Drs. Moshovos and Sohi knew of specific, material information in those references. Identifying the same problem as the patent in suit or discussing a related solution does not render a reference "but-for" material. Since that is all the "specific information" Drs. Moshovos and Sohi are alleged to have known about the allegedly undisclosed Steely Patent and Smith Article, Apple's scienter allegations are deficient under Exergen.
Second, to allege the requisite "deliberate decision" to deceive, Apple alleges generally that Drs. Moshovos and Sohi (1) knew of the Steely Patent and Smith Article; and (2) had a financial interest in seeing the `752 patent issue. The first allegation necessarily fails because, as discussed above, Apple has not sufficiently alleged that they knew of material portions of those references. As to the second allegation, the Federal Circuit has held that "any financial reward does not alone show an intent to deceive the USPTO." Research Corp. Techs., Inc. v. Microsoft Corp., 536 F.3d 1247, 1253 (Fed. Cir. 2008). Thus, Apple's inequitable conduct counterclaim again flounders.
Third, some of the "deceptive conduct" Apple alleges does not even clearly constitute deception. For example, Apple alleges that "during prosecution of the '752 patent, Dr. Moshovos and Dr. Sohi made affirmative statements about the state of the art that were false in light of the Steely Patent." (Counterclaims (dkt. #40) ¶ 34.) More specifically, according to Apple, Professors Sohi and Moshovos made false statements in response to an October 8, 1997, Office Action in which the Examiner rejected certain pending claims as anticipated by U.S. Patent No. 5,555,432 ("Hinton").
These factual allegations, however, seem to fold in upon themselves. A statement concerning the Hinton reference and its disclosures can hardly be rendered "false in light of the Steely Patent" for the simple reason that it is a different reference. In fact, even Apple concedes that "the applicants' statement that Hinton did not disclose a particular type of data predictor may have been technically true." (Def.'s Br. Opp'n (dkt. #46) 18.) A fair reading of the allegations in the counterclaims, therefore, raises the question how the Steely Patent renders a "technically true" statement regarding an entirely different reference vulnerable to an inequitable conduct challenge. Indeed, it is unclear how the Hinton reference plays into the validity of the `752 patent at all, at least on the face of the pleadings.
Dismissal of a claim is warranted when the pleading "fails to allege enough facts to raise a reasonable expectation that discovery will reveal evidence supporting [those] allegations." Semiconductor Energy, 749 F. Supp. 2d at 901. This is precisely the case here. There is not even a reasonable expectation that discovery will support the allegations as pled because "anticipation requires all elements of a claim to be disclosed within a single reference," not two references. Cohesive Techs., Inc. v. Waters Corp., 543 F.3d 1351, 1364 (Fed. Cir. 2008). Thus, whether or not the Steely Patent disclosed the claim element in question has no relevance to overcoming the Examiner's anticipation rejection regarding Hinton.
WARF asks the court to dismiss Apple's counterclaim without leave to amend, arguing that the "sheer number of deficiencies" in the pleading demonstrates that Apple cannot meet the pleading standard of Rule 9(b). A court should ordinarily grant leave to amend "freely . . . when justice so requires." Fed. R. Civ. P. 15(a)(2). Absent prejudice, dilatory motives or repeated failures to cure, this means that leave to amend is generally denied only where an amendment would be "futile," Foman v. Davis, 371 U.S. 178, 182 (1962), meaning that the pleading could not survive a second motion to dismiss. Such is not the case here.
While Apple's pleadings suffer from the myriad deficiencies set forth above, the court is not persuaded that an amendment would be futile. As noted above, Apple may be able to plead sufficient facts to comply with the high level of particularity required by Rule 9(b) and Exergen. There is some question as to whether certain of Apple's theories are foreclosed as a matter of law,
IT IS ORDERED that plaintiff Wisconsin Alumni Research Foundation's motion to dismiss the inequitable defense counterclaim (dkt. #44) is GRANTED IN PART and DENIED IN PART, as set forth in the opinion above. This counterclaim is, therefore, DISMISSED without prejudice.